Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Associated-dysfunction Steatohepatitis (MASH)”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Large-scale testing (Phase 3)Active Not RecruitingNCT06161571
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
NASH/MASHNAFLD/MASLD
Akero Therapeutics, Inc 700
Not applicableNot Yet RecruitingNCT07530419
What this trial is testing

Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty LiverLiver Fibrosis
Seoul National University Hospital 95
Not applicableLooking for participantsNCT07330830
What this trial is testing

Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Centre Hospitalier Universitaire de la Guadeloupe 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Not applicableLooking for participantsNCT07188220
What this trial is testing

Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07016633
What this trial is testing

To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Changchun Intellicrown Pharmaceutical Co. LTD 40
Not applicableStudy completedNCT06647095
What this trial is testing

New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
HealthySimple Steatosis (SS)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
General University Hospital, Prague 172
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Large-scale testing (Phase 3)WithdrawnNCT06594523
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis

Who this might be right for
MASHNASHMetabolic Dysfunction-associated Steatohepatitis+3 more
Sagimet Biosciences Inc.
Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Not applicableLooking for participantsNCT07013916
What this trial is testing

Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisMASH With FibrosisSteatosis of Liver
Queen Mary University of London 72
Testing effectiveness (Phase 2)Study completedNCT06675929
What this trial is testing

Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Who this might be right for
Compensated Liver CirrhosisMetabolic Dysfunction Associated Steatohepatitis (MASH)
Boehringer Ingelheim 28
Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07527910
What this trial is testing

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 204
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Early research (Phase 1)Looking for participantsNCT06836609
What this trial is testing

Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis
Regeneron Pharmaceuticals 132
Not applicableStudy completedNCT07389122
What this trial is testing

Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight

Who this might be right for
Obesity & OverweightMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Type 2 Diabetes+1 more
University of Bologna 110
Large-scale testing (Phase 3)WithdrawnNCT06692283
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

Who this might be right for
MASLDMASHNASH+4 more
Sagimet Biosciences Inc.
Large-scale testing (Phase 3)Looking for participantsNCT06632444
What this trial is testing

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim 1,800
Load More Results